1. Home
  2. Research and Funding
  3. Current Funding Opportunities
  4. Notice of Specialist Interest (NOSI): Advancing Polycystic Kidney Disease (PKD) Research through Catalytic Tool and Technology Development

Notice of Specialist Interest (NOSI): Advancing Polycystic Kidney Disease (PKD) Research through Catalytic Tool and Technology Development

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is issuing this Notice of Special Interest (NOSI) to announce the opportunity for investigators to apply for funding for developing novel tools and technologies that enable new lines of scientific inquiry and/or treatment, prevention, or diagnosis of Polycystic Kidney Disease (PKD).

Funding Opportunity Details

NOT-DK-20-034
PAR-20-140

Christine Maric-Bilkan, Ph.D.; Susan Mendley, M.D.

 
NOTE: The NIDDK does not co-sponsor the NIH Exploratory Developmental Research Grant Program (Parent R21). 
The NIDDK will continue to accept R21 applications submitted in response to targeted NIDDK solicitations.

Key Dates

6/17/2020

This notice applies to due dates on or after October 16, 2020 and subsequent receipt dates through January 8, 2023.

Applications for this initiative must be submitted using the following funding opportunity announcement (FOA) or any reissues of this announcement through the expiration date of this notice.

PAR-20-140: Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)

All instructions in the SF424 (R&R) Application Guide and the funding opportunity announcement used for submission must be followed, with the following additions:
  • For funding consideration, applicants must include “NOT-DK-20-034” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.
  • The budget should include travel funds for the Program Director/Principal Investigator(PD/PI) to attend the 3-day PKD Research Consortium Annual Meeting, anticipated to be held at the NIH main campus or in the Washington, DC metro area.